Ginkgo Bioworks Holdings, Inc. (DNA)
Largest Insider Buys in Sector
DNA Stock Price History Chart
DNA Stock Performance
About Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Insider Activity of Ginkgo Bioworks Holdings, Inc.
Over the last 12 months, insiders at Ginkgo Bioworks Holdings, Inc. have bought $786,565 and sold $2.26M worth of Ginkgo Bioworks Holdings, Inc. stock.
On average, over the past 5 years, insiders at Ginkgo Bioworks Holdings, Inc. have bought $873,283 and sold $54.16M worth of stock each year.
Highest buying activity among insiders over the last 12 months: SLOAN HARRY (director) — $1.09M. Sankar Shyam (director) — $1.03M.
The last purchase of 625,000 shares for transaction amount of $514,750 was made by Sankar Shyam (director) on 2024‑05‑15.
List of Insider Buy and Sell Transactions, Ginkgo Bioworks Holdings, Inc.
| 2025-01-06 | Sale | See remarks | 645 0.0011% | $11.72 | $7,558 | -12.45% | ||
| 2025-01-06 | Sale | See remarks | 324 0.0006% | $11.72 | $3,797 | -12.45% | ||
| 2024-12-04 | Sale | See remarks | 741 0.0012% | $9.64 | $7,146 | -2.02% | ||
| 2024-12-04 | Sale | See remarks | 330 0.0005% | $9.64 | $3,183 | -2.02% | ||
| 2024-11-04 | Sale | See remarks | 1,322 0.002% | $7.58 | $10,015 | +23.72% | ||
| 2024-11-04 | Sale | See remarks | 333 0.0005% | $7.58 | $2,523 | +23.72% | ||
| 2024-10-04 | Sale | See remarks | 1,217 0.002% | $8.35 | $10,163 | +3.24% | ||
| 2024-10-04 | Sale | See remarks | 306 0.0005% | $8.35 | $2,555 | +3.24% | ||
| 2024-09-12 | Sale | See remarks | 1,148 0.0014% | $6.17 | $7,085 | +32.85% | ||
| 2024-09-12 | Sale | See remarks | 316 0.0004% | $6.17 | $1,950 | +32.85% | ||
| 2024-08-02 | Sale | See remarks | 63,567 0.0036% | $0.29 | $18,244 | -33.94% | ||
| 2024-08-02 | Sale | See remarks | 17,486 0.001% | $0.29 | $5,018 | -33.94% | ||
| 2024-07-02 | Sale | See remarks | 49,162 0.0032% | $0.33 | $16,027 | -37.23% | ||
| 2024-07-02 | Sale | See remarks | 13,520 0.0009% | $0.33 | $4,408 | -37.23% | ||
| 2024-06-03 | Sale | See remarks | 48,866 0.0054% | $0.55 | $26,827 | -56.69% | ||
| 2024-06-03 | Sale | See remarks | 13,440 0.0015% | $0.55 | $7,379 | -56.69% | ||
| 2024-05-16 | Sale | director | 265,000 0.044% | $0.83 | $220,030 | -71.36% | ||
| 2024-05-15 | director | 625,000 0.1029% | $0.82 | $514,750 | -71.36% | |||
| 2024-05-14 | Sale | director | 1.73M 0.3212% | $0.93 | $1.61M | -72.08% | ||
| 2024-05-14 | director | 297,619 0.0544% | $0.91 | $271,815 | -72.08% |
Insider Historical Profitability
| DEKKERS MARIJN E | director | 5515364 9.5955% | $12.90 | 0 | 3 | |
| Sankar Shyam | director | 2356874 4.1004% | $12.90 | 2 | 0 | +15.91% |
| SLOAN HARRY | director | 718540 1.2501% | $12.90 | 2 | 0 | +15.91% |
| Dmytruk Mark E. | See remarks | 33216 0.0578% | $12.90 | 0 | 31 | |
| Coen Steven P. | See remarks | 7288 0.0127% | $12.90 | 0 | 9 | |
| Shetty Reshma P. | See remarks | 12374544 21.5288% | $12.90 | 0 | 164 | |
| Canton Barry | 10 percent owner | 12374544 21.5288% | $12.90 | 0 | 164 | |
| Kelly Jason R | See remarks | 3894680 6.7758% | $12.90 | 0 | 166 | |
| HENRY CHRISTIAN O | director | 1234378 2.1475% | $12.90 | 0 | 14 | |
| Fallon Marie E. | See remarks | 183010 0.3184% | $12.90 | 0 | 9 | |
| LEVINSON ARTHUR D | CHAIRMAN & CEO | 9268 0.0161% | $12.90 | 0 | 25 | |
| EBERSMAN DAVID A | EVP & CHIEF FINANCIAL OFFICER | 8097 0.0141% | $12.90 | 0 | 7 | |
| SANDERS CHARLES A | director | 2000 0.0035% | $12.90 | 0 | 2 | |
| GARNICK ROBERT L | SENIOR VICE PRESIDENT | 1710 0.003% | $12.90 | 0 | 9 | |
| Tessier-Lavigne Marc | EVP, RESEARCH DRUG DISCOVERY | 1159 0.002% | $12.90 | 0 | 1 | |
| CLARK IAN T | EVP-COMMERCIAL | 668 0.0012% | $12.90 | 0 | 11 | |
| LAVIGNE LOUIS J JR | EVP AND CFO | 0 0% | $12.90 | 0 | 7 | |
| RICHMOND MARK SIR | director | 0 0% | $12.90 | 0 | 6 | |
| SCHELLER RICHARD H | EVP-RESEARCH | 0 0% | $12.90 | 0 | 40 |